In line with the cell function experiments in vitro, we demonstrated that the expression of PYGL was closely associated with HNSCC’s growth and metastasis in vivo, and further revealed its relationship with cisplatin’s resistance in the chemotherapy of HNSCC. The gene discussed is PYGL; the disease is head and neck squamous cell carcinoma.